Oral cryotherapy can significantly reduce oral mucositis but not acute GVHD incidence in Flu/Mel conditioning allo-SCT
Authors:
- 25 July 2011
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 47 (5) , 739-741
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Intestinal Damage Determines the Inflammatory Response and Early Complications in Patients Receiving Conditioning for a Stem Cell TransplantationPLOS ONE, 2010
- Oral cryotherapy reduces mucositis and improves nutrition – a randomised controlled trialJournal of Clinical Nursing, 2010
- Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2Bone Marrow Transplantation, 2009
- Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experienceHaematologica, 2008
- Updated clinical practice guidelines for the prevention and treatment of mucositisCancer, 2007
- Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated DonorInternational Journal of Hematology, 2006
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005
- Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipientsSupportive Care in Cancer, 2005
- Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationBlood, 2001